Myriad Genetics reported $166M in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Accelerate Diagnostics AXDX:US 8.21M 1.27M
Agilent A:US $ 1813M 229M
Becton, Dickinson and BDX:US $ 7080M 423M
Bio Rad Laboratories BIO:US $ 613.71M 34.62M
Biocept BIOC:US $ 14.1M 2.32M
Bruker BRKR:US $ 818.4M 62.1M
Danaher DHR:US $ 7556M 9M
Exact Sciences EXAS:US $ 443.33M 37.62M
Fluidigm FLDM:US $ 47.17M 2.4M
Hologic HOLX:US $ 1000.9M 304.2M
Illumina ILMN:US $ 1490M 397M
Mettler Toledo International MTD:US 1.12B 31.17M
Nanostring Technologies NSTG:US $ 51.84M 2.26M
Orasure Technologies OSUR:US $ 55.59M 12.48M
Pacific Biosciences Of California PACB:US $ 134.67M 73.66M
Perkinelmer PKI:US $ 1043.81M 219.24M
Quest Diagnostics DGX:US $ 1577M 123M
Quidel QDEL:US $ 900M 407.34M
Repligen RGEN:US $ 423.52M 0.81M
Thermo Fisher Scientific TMO:US $ 10997M 1073M
Veracyte VCYT:US $ 59.34M 3.2M
Waters WAT:US $ 1484.37M 796.54M